Fertility Medication Information

Description

Side Effects

Headaches, nausea

Administration Site

Subcutaneous (SQ)

Description

Used to prevent premature LH surge in women undergoing controlled ovarian stimulation.

Side Effects

Headaches, nausea

Administration Site

Subcutaneous (SQ)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Subcutaneous (SQ)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Subcutaneous (SQ) or Intramuscular (IM)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Intramuscular (IM)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Subcutaneous (SQ)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Subcutaneous (SQ)

Description

Used to induce ovulation and is responsible for stimulating growth and the maturation of the eggs.

Side Effects

Occasionally headache and slight water retention and moodiness.

Administration Site

Subcutaneous (SQ)

Description

Simulates the body’s normal LH surge causing the final maturation of the eggs. It is expected that ovulation will take place 38-40 hours after HCG.

Side Effects

Occasionally low abdominal (pelvic) discomfort.

Administration Site

Intramuscular (IM)

Description

Simulates the body’s normal LH surge causing the final maturation of the eggs. It is expected that ovulation will take place 38-40 hours after injection.

Side Effects

Occasionally low abdominal (pelvic) discomfort.

Administration Site

Subcutaneous (SQ)

Description

Progesterone is the hormone necessary for the preparation of the uterine lining for the implantation of the embryo and the maintenance of early pregnancy.

Side Effects

Breast tenderness, injection site tenderness, vaginal discharge.

Administration Site

Intramuscular (IM)

Description

Saizen® [somatropin (rDNA origin) for injection] is a prescription medicine indicated for the treatment of growth hormone deficiency (GHD) to replace growth hormone in adults because of either a deficiency that started as a child or started as an adult due to pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma.

Side Effects

Injection site tenderness, low levels of thyroid hormone (hypothyroidism), pain in joints and muscle pain, swelling associated with fluid retention, tingling and numbness, unusual skin sensations, carpal tunnel syndrome, increased blood sugar (hyperglycemia)

Administration Site

Intramuscular injection (IM)